✦ LIBER ✦

Economic Impact of Asthma Therapy with Fluticasone Propionate, Montelukast, or Zafirlukast in a Managed Care Population

✍ Scribed by Dr. Dev S. Pathak; Dr. E. Anne Davis; Dr. Richard H. Stanford

Book ID: 115048525
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 52 KB
Volume: 22
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.22.3.166.33548

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Efficacy and Cost of Asthma

Comparative Efficacy and Cost of Asthma Care in Children with Asthma Treated with Fluticasone Propionate and Montelukast

✍ David A. Stempel; Denise T. Kruzikas; Ranjani Manjunath 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 115 KB

PRS5: IMPACT OF INHALED CORTICOSTEROIDS

PRS5: IMPACT OF INHALED CORTICOSTEROIDS (FLUTICASONE PROPIONATE) ON ECONOMIC OUTCOMES IN A MANAGED CARE ENVIRONMENT

✍ V Oates; B Vaziri; J Ober; L Gothard 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Prescribing of Fluticasone Propionate/Sa

Prescribing of Fluticasone Propionate/Salmeterol Combinations as Initial Therapy for Patients With Asthma in a Commercially-Insured Population

✍ Friedman, H.S.; Wilcox, T.K.; Reardon, G.; Crespi, S.; Yawn, B.P. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

PRP10: PREDICTING THE BENEFIT OF OPTIMIZ

PRP10: PREDICTING THE BENEFIT OF OPTIMIZING SEVERE ASTHMA MANAGEMENT IN A MANAGED CARE SETTING:A COST-BENEFIT ANALYSIS COMPARING THE COMBINATION OF FLUTICASONE PROPIONATE AND SALMETEROL (FPS) AND ZAFIRLUKAST

✍ A Joglekar; C Chao; P Kadison 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Montelukast or salmeterol combined with

Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial)

✍ L. BJERMER; H. BISGAARD; J. BOUSQUET; L.M. FABBRI; A. GREENING; T. HAAHTELA; S.T 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 199 KB

1585 IMPACT OF LENGTH OF 5-ARI THERAPY O

1585 IMPACT OF LENGTH OF 5-ARI THERAPY ON CLINICAL OUTCOMES AND COSTS IN A POPULATION OF MANAGED CARE PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

✍ Kruep, Eric; Gruschkus, Stephen; Poston, Sara; Goodwin, Bridgett; Chaudhari, Sha 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 45 KB